Literature DB >> 32364856

Self-Help Groups And Medication Use In Opioid Addiction Treatment: A National Analysis.

Hefei Wen1, Benjamin G Druss2, Brendan Saloner3.   

Abstract

Self-help groups and medications (buprenorphine, methadone, and naltrexone) both play important roles in opioid addiction treatment. The relative use of these two treatment modalities has not been characterized in a national study. Using national treatment data, we found that self-help groups were rarely provided in conjunction with medication treatment: Among all adult discharges from opioid addiction treatment in the period 2015-17, 10.4 percent used both self-help groups and medications, 29.2 percent used only medications, 29.8 percent used only self-help groups, and 30.5 percent used neither self-help groups nor medications. Use of self-help groups without medication is most common in residential facilities, among those with criminal justice referrals, and among uninsured or privately insured patients, as well as in the South and West regions of the US. These subgroups may be important targets for future efforts to identify and overcome barriers to medication treatment and create multimodal paths to recovery.

Entities:  

Keywords:  Addiction; Drug use; Health policy; Medicaid; Pharmaceuticals; Private health insurance; Uninsured; substance abuse

Mesh:

Substances:

Year:  2020        PMID: 32364856      PMCID: PMC7853764          DOI: 10.1377/hlthaff.2019.01021

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  21 in total

Review 1.  Self-help organizations for alcohol and drug problems: toward evidence-based practice and policy.

Authors:  Keith Humphreys; Stephen Wing; Dennis McCarty; John Chappel; Lewi Gallant; Beverly Haberle; A Thomas Horvath; Lee Ann Kaskutas; Thomas Kirk; Daniel Kivlahan; Alexandre Laudet; Barbara S McCrady; A Thomas McLellan; Jon Morgenstern; Mike Townsend; Roger Weiss
Journal:  J Subst Abuse Treat       Date:  2004-04

2.  Court personnel attitudes towards medication-assisted treatment: A state-wide survey.

Authors:  Barbara Andraka-Christou; Meghan Gabriel; Jody Madeira; Ross D Silverman
Journal:  J Subst Abuse Treat       Date:  2019-06-28

3.  The Trump Administration's Actions to Address the Opioid Public Health Crisis.

Authors:  Elinore F McCance-Katz; Brett P Giroir
Journal:  JAMA Psychiatry       Date:  2019-01-01       Impact factor: 21.596

4.  Correlates of Opioid Abstinence in a 42-Month Posttreatment Naturalistic Follow-Up Study of Prescription Opioid Dependence.

Authors:  Roger D Weiss; Margaret L Griffin; David E Marcovitz; Blake T Hilton; Garrett M Fitzmaurice; R Kathryn McHugh; Kathleen M Carroll
Journal:  J Clin Psychiatry       Date:  2019-03-26       Impact factor: 4.384

5.  Characteristics and prescribing practices of clinicians recently waivered to prescribe buprenorphine for the treatment of opioid use disorder.

Authors:  Christopher M Jones; Elinore F McCance-Katz
Journal:  Addiction       Date:  2018-10-15       Impact factor: 6.526

6.  Medications for opioid use disorder in the Department of Veterans Affairs (VA) health care system: Historical perspective, lessons learned, and next steps.

Authors:  Jessica J Wyse; Adam J Gordon; Steven K Dobscha; Benjamin J Morasco; Elizabeth Tiffany; Karen Drexler; Friedhelm Sandbrink; Travis I Lovejoy
Journal:  Subst Abus       Date:  2018       Impact factor: 3.716

7.  The trouble with morality: the effects of 12-step discourse on addicts' decision-making.

Authors:  David Frank
Journal:  J Psychoactive Drugs       Date:  2011 Jul-Sep

8.  Community correctional agents' views of medication-assisted treatment: Examining their influence on treatment referrals and community supervision practices.

Authors:  Shannon Gwin Mitchell; Jennifer Willet; Laura B Monico; Amy James; Danielle S Rudes; Jill Viglione; Robert P Schwartz; Michael S Gordon; Peter D Friedmann
Journal:  Subst Abus       Date:  2016       Impact factor: 3.716

9.  Medicaid Benefits For Addiction Treatment Expanded After Implementation Of The Affordable Care Act.

Authors:  Christina M Andrews; Colleen M Grogan; Bikki Tran Smith; Amanda J Abraham; Harold A Pollack; Keith Humphreys; Melissa A Westlake; Peter D Friedmann
Journal:  Health Aff (Millwood)       Date:  2018-08       Impact factor: 6.301

10.  Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone.

Authors:  Paul J Fudala; T Peter Bridge; Susan Herbert; William O Williford; C Nora Chiang; Karen Jones; Joseph Collins; Dennis Raisch; Paul Casadonte; R Jeffrey Goldsmith; Walter Ling; Usha Malkerneker; Laura McNicholas; John Renner; Susan Stine; Donald Tusel
Journal:  N Engl J Med       Date:  2003-09-04       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.